Active options: PFE MSTR PLTR NIO MSFT OXY DJT RIOT BA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- Nasdaq futures underpinned by strong AI forecasts; focus on earnings, data
- Fed's Williams says rate hikes possible if inflation persists
- Citi says buy these 3 chip stocks on pullback
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Deutsche Bank raises S&P 500 earnings estimates on the back of the solid Q2 beats
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
Pfizer (PFE) PT Raised to $31 at CFRA
October 7, 2024 2:55 PM EDTCFRA analyst Sel Hardy raised the price target on Pfizer (NYSE: PFE) to $31.00 (from $30.00) while maintaining a Hold rating.
The analyst comments "We raise our target price to $31 from $30, 10.9x our 2025 EPS, below PFEs historical forward P/E average. We lift our 2024 EPS... More
